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Abstract: In the mid-1950s, Bert Lester Vallee and his colleague Marvin Margoshes discovered a
molecule referred to today as metallothionein (MT). Meanwhile, MTs have been shown to be common
in many biological organisms. Despite their prevalence, however, it remains unclear to date what
exactly MTs do and how they contribute to the biological function of an organism or organ. We
investigate why biochemical research has not yet been able to pinpoint the function(s) of MTs. We
shall systematically examine both the discovery of and recent research on Dr. Vallee’s beloved family
of MT proteins utilizing tools from philosophy of science. Our analysis highlights that Vallee’s initial
work exhibited features prototypical of a developing research tradition: it was upward-looking,
exploratory, and utilized mere interactions. Since the 1960s, MT research has increasingly become
intervention- and hypothesis-based while it remained largely upward-looking in character. Whilst
there is no reason to think that upward-looking research cannot successfully yield structure-function
mappings, it has not yet been successful in the case of MTs. Thus, we suggest it might be time to
change track and consider other research strategies looking into the evolution of MTs. Recent studies
in mollusks render research in this direction worthy of pursuit.
Keywords: exaptation; exploratory research; compensation; convergent evolution; metallothionein
(MT); moonlighting; multiple realization; protein function; research strategies; scientific discovery;
scientific pursuit; upward-looking research; vestiges
1. Introduction
After the Second World War, several scientists have been interested in studying the
metabolism of metals, especially iron, zinc, and copper in biological organisms. Bert Lester
Vallee, who worked at Harvard Medical School and MIT at the time, was a pioneer in
the field. After he graduated from New York University with a degree in medicine in
1943, he recognized the potential of spectroscopy to detect metals in biological systems.
Regarded as a genius by his colleagues and known for sometimes rigorous questioning of
assumptions, Dr. Vallee, as he preferred to be called, had already been reporting extensively
about alcohol dehydrogenase (ADH), a metalloenzyme [1]. In the mid-1950s, Vallee came
across translations of two publications form Doklady Akademii Nauk SSSR, the official
journal of the USSR Academy of Science, dating to 1941 and 1943, and reporting cadmium
in several biological systems such as the Aspen tree, algae and other marine species as
well as amphibians, reptiles, and even mammals [2]. At first, Dr. Vallee was skeptical
about the validity of the data reported. For one thing, cadmium “ . . . never has been
demonstrated to be an integral part of a natural product” (1957, p. 4813) [3]. For another,
A.O. Vinar (the author of one of those manuscripts) neither mentioned any references in
his paper, nor did he employ established methodology. Instead, Vinar reported the results
of self-developed colorimetric and spectrographic techniques to measure the amount of
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cadmium in biological systems. Adding to this potentially problematic methodology, Vallee
failed to reproduce some of the experimental results Vinar had reported. For instance,
Vallee was unable to induce hypoglycemia in a mammalian species upon injection with
cadmium chloride (CdCl2) in his own laboratory [2]. Still, Vallee’s interest was sparked.
Indeed, he had been studying zinc in biological organisms for years and he could not fail
to notice that zinc and cadmium are chemically very similar substances: “The conjoint
presence of cadmium and zinc in zinc ores, the difficulties encountered in separating them
and ascertaining their identities by chemical means implied that biological matter might
discriminate less between their absorption, utilization and perhaps even function than
might be thought. Hence, I decided to search for cadmium proteins and enzymes, their
biological roles, normal and abnormal metabolism, much as I had proceeded to study the
biological role of zinc” (1978, p. 24) [4]. Therefore, Vallee set out to search for cadmium
in mammals himself. Together with Marvin Margoshes, he analyzed tissues of human,
horse, cow, hog, and sheep kidneys. In 1957, Vallee and Margoshes published a report
stating that they actually did identify cadmium in these species [3]. They continued to
examine the kidney cortex of equines, which seemed to contain relatively high amounts
of cadmium, to try and identify what chemical compound cadmium is part of in the
kidney cortex. While the exact relation to zinc remained unclear, Vallee and Margoshes
concluded that their results were “ . . . indicative of a low molecular weight protein,
probably containing a small number of cadmium atoms per molecule.” (1957, p. 4813) [3]
Though its biological function and significance remained completely unclear, this marks
the discovery of metallothionein (MT).
It took until 1960 for the term “metallothionein” to be first coined [5]. The name is
descriptive in nature. It points to a bond between a metal ion and thionein (a cysteine
rich apoprotein) rather than describing a function of these kinds of proteins per se, as is
the case, for example, with the ADHs discovered a couple of years earlier [6]. Though it
was not immediately obvious what MTs can and cannot do, and what purpose they might
serve in a living organism, MTs became the focus of an intense and often controversial
corpus of research since the 1960s (e.g., [7–12]). From a biochemical perspective, there is
no question that MTs have unique properties. Besides, they are extremely widespread
across taxonomic groups. Based on genetic information, 15 families of MTs have been
identified in mammalian and nonmammalian animal species to date and four further
families have been identified in plant species [13,14]. Both their biochemical characteristics
and their taxonomic prevalence speak to MTs serving some important biological role(s). In
fact, a quick search on PubMed Central (pubmed.ncbi.nlm.nih.gov/ accessed 07.04.2021)
using just the term “metallothionein” as a query found over 18 thousand hits in the
literature category and 34 thousand under the protein category. Six decades after their
initial discovery, after literally thousands of studies describing their structure, biochemical
characteristics, and tissue distributions, however, the biological function(s) of MTs still
remains enigmatic [15,16].
In this paper, we shall discuss both the discovery of and also recent research on MTs
from a philosophy of science point of view. We shall systematically analyze the kind of
research conducted on MTs so far and which new research strategies might be worthy
of pursuit given the status quo. Our manuscript is structured as follows. In Section 2
we shall discuss the features that Dr. Vallee’s initial research on MTs exhibits, how these
contrast with dominant research strategies in biochemistry and related disciplines such as
pharmacology, and how to account for them from a philosophy of science point of view.
We shall find that central features of Vallee’s early work are prototypical of a developing
research tradition: it was upward-looking, exploratory, and utilized mere interactions. In
Section 3, we shall turn to more recent research on the vertebrate MT family. Since the 1960s,
MT research has increasingly become intervention- and hypothesis-based while it remained
largely upward-looking in character. We shall review three specific hypotheses with respect
to which biological functions different MTs might serve. Though hypothesis-based search
for one-to-one molecule-function mappings has been successful in other cases, as we shall
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outline in Section 4, this strategy has not yielded a satisfactory result for MTs to date.
Against this backdrop, we suggest, in Section 5, that whilst there is nothing systematically
amiss with early or contemporary MT research, it might be time to change track and
consider other research strategies to understand the biological and evolutionary role(s)
of MTs. Indeed, recent hypotheses proposed in the context of MT research in mollusks
support our suggestions. We conclude that studying the evolution of MTs offers a research
direction worthy of pursuit for understanding MT function(s) in vertebrates and beyond.
2. Classifying Vallee’s Experiments
The dominant picture of research in biochemistry and related disciplines such as
pharmacology is that scientists start with a function. They notice, say, that some plants
have the ability to convert light into energy and wonder how that works. Or they get
interested in how blood pressure is kept constant or muscle growth is being regulated
by an organism. In each of these cases, researchers start working from an explanandum
(a phenomenon to be explained) to an explanation of how that phenomenon or function
is elicited. Paradigmatically, much of the research needed here will be focused on de-
composing the system in question, looking at what the different parts of the system do
precisely, and how they work together to elicit the explanandum. This analysis may take
different forms and run through multiple iterations. Yet, the essential rationale behind any
version of this downward-looking approach might be captured by the slogan “divide and
conquer!”—researchers are breaking up the system into units, and associating each unit
with a specific function [17,18].
2.1. Downward-Looking versus Upward-Looking
While downward-looking is a good strategy in many cases, this is not all there is to
science and scientific inquiry. Recent philosophical accounts of discovery and explanation
have been highlighting that identifying the mechanism responsible for a phenomenon to
be explained may involve bottom-up or upward-looking research along with downward-
looking decomposition strategies (see Figure 1) [19–21]. That is to say, rather than just
taking a system apart and studying what the different components (parts) do in isolation,
researchers are frequently studying individual components while they are looking for
what these components do as part of an overall system. If you want to understand, say,
hippocampal long-term potentiation (LTP), it is not only interesting to see that N-methyl-
D-aspartate (NMDA) receptors are part of the mechanism in question. You might want to
establish how NMDA receptors contribute to LTP—how they work, how they are triggered,
and what happens to LTP if there are no NMDA receptors. Therefore, even if you are
starting from an explanandum, LTP in this case, at some point you might need to employ
upward-looking research focusing on how a component, in this example the NMDA
receptor, contributes to the explanandum.
To illustrate this downward-looking research strategy, we might also consider the
case of penicillinase. Almost a decade after Alexander Fleming’s discovery of penicillin
in cell cultures of the Gram-positive Staphylococcus aureus contaminated by the fungus
Penicillium rubens, attention was shifted to elucidate antibiotic resistance observed in some
bacteria [22]. Researchers prepared purified extracts from crushed penicillin resistant Es-
cherichia coli, incubated them with penicillin to then introduce it to bacterial cultures known
to be sensitive to penicillin [23]. The processed penicillin demonstrated a significantly lower
antimicrobial effect than regular penicillin. When the same kind of extract was prepared
from penicillin-sensitive Staphylococcus aureus no such effect was observed. Researchers
continued to look for the active substance responsible for this effect. In 1940, they identified
a protein, termed penicillinase, which they held responsible for inactivating penicillin [24].
Further studies confirming the different sensitivity towards penicillin due to the absence or
presence of penicillinase were conducted [25]. Put briefly, we might summarize the case
as follows: scientists started searching for what makes bacteria resistant to penicillin by
downward-looking research. They crushed resistant bacteria and examined their compo-
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nents. Once they identified a likely candidate, in this case penicillinase, responsible for the
phenomenon, here penicillin-resistance, they assessed its relevance in an upward-looking
experiment by adding penicillinase to penicillin-sensitive bacteria.
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Figure 1. Illustrating the differences between upward looking and downward looking approaches
to research. Panel (A) represents the downward looking approach, e.g., decomposition. Panel (B),
represents the upward looking approach, e.g., composition or “re-composition”.
What does this tell us with respect to the case of MTs? With the distinction between
upward-looking and downward-looking experiments in place we can clearly recognize
Vallee’s early research on MTs, along with most recent MT research we will discuss in
Section 3 below, as upward-looking; for it starts from a molecule rather than a function
we are trying to explain. This is intriguing. Not because upward-looking research is rare
in biochemistry and related disciplines per se. But because in the case of MTs it was, and
to a large extent still is, the starting point. MTs have not been identified by some sort of
downward-looking study. It is noteworthy that not each of the MTS found to date have been
identified through upward looking research, though. MT3, for instance, was identified after
the observation that extracts from brain cells of Alzheimer’s disease patients supported the
survival of rat neuronal cell cultures and was initially called growth inhibitory factor (GIF).
Before we continue discussing the nature and prospects of upward-looking research, let us
turn to two other distinctions which will be helpful in understanding what sets Vallee’s
discovery of MTs apart from much other biochemical research.
2.2. Interventions versus Mere Interactions
Experimental work is often characterized in terms of interventions. While the notion
is widely used in the empirical sciences to refer to any kind of manipulation, philosophers
of science distinguish between different kinds of experimental strategies and manipula-
tions. In this context, the notion “intervention” is reserved for those manipulations which
systematically wiggle some, Factor X, in order to elicit changes in another, Factor Y (cf.
e.g., see [26,27]). Researchers may intervene, i.e., inhibit or trigger, for instance, into the
activity of some part of a system (X) to study how that intervention affects the system’s
overall behavior (Y)—or vice versa [28]. We may study, say, how penicillinase affects
penicillin-resistance or how damaged NMDA receptors interfere with LTP. Intervention-
based experimentation is experimentation which manipulates something in order to study
the effects it elicits.
Intervention-based research can be contrasted with merely interactive experimenta-
tion [29]. Mere interactions are a different form of experimental manipulation; they serve
to uncover structures and organization and make accessible features of a system without
changing these features. Cases in point are among many others the application of staining
techniques, centrifugation of fluids, optogenetics, or—as in Vallee’s case—spectroscopy.
In any of these cases, the system is affected, and some aspects of it are being changed,
e.g., by staining them. But while interventions are applied to study which effects certain
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manipulations will have on the system or its parts, mere interactions are employed pre-
cisely because they have certain well-known effects, such as attaching marker molecules
to certain particles. Unlike interventions, mere interactions do not seek to interfere with
what a system or any given part of it does. Rather, mere interactions are sophisticated
tools for observation which help scientists uncover features of a system or organism not
otherwise accessible.
With this distinction in place, we can recognize, that at least initially, Vallee’s research
on the kidneys of various species was a case of mere interactions. He did not seek to
change the cadmium content of the tissues he studied to establish what happens when
cadmium content is raised or lowered. Rather, he measured it with the technology available
to him. He also did not change the kind of protein cadmium was bound to but analyzed
its biochemical properties through merely interactive experimentation. Note that while
Vallee’s initial mere interactions might be considered a sort of decomposition, they are
not downward looking in the sense that he was searching for a component relevant to a
specific function he sought to explain (see Section 2.1 and Figure 1).
2.3. Hypothesis-Testing versus Exploratory Research
Interventions in the sense just described are frequently carried out to test specific
research hypotheses. If we hypothesize that penicillinase plays an important role in
penicillin-resistance, for instance, we can test that hypothesis by intervening into, i.e.,
changing, the presence of penicillinase and observing the effects this has on penicillin-
resistance. This approach might be contrasted with exploratory research, viz. research
that does not test hypotheses or theories. Exploratory experiments are often conducted to
map the functional architecture of a system without having a pre-established theory, or
to delineate phenomena from their surroundings [30–34]. Exploratory experimentation
is very popular before a scientific theory or research tradition is established and before
specific hypotheses can be formulated. While it seems tempting to associate exploratory
research with mere interactions and contrast it with hypothesis-testing interventions, this
dichotomy is premature. In fact, exploratory research can utilize interventions as well.
For illustration consider Hubel and Wiesel’s systematic research on cat V1, or Charles
Dufay’s “discovery” of the two electricities (positive and negative) [35,36]. In the same
way, hypothesis-testing research can utilize mere interactions if, say, we are hypothesizing
whether a chemical substance or a biomolecule we can stain for are contained in a sample
or not [37].
To summarize the terminology just introduced: experiments can be (i) either ex-
ploratory or designed to test specific hypotheses, they can (ii) utilize interventions (study-
ing the effects of a manipulation) or mere interactions (manipulations serving to uncover
certain structural features), and they can (iii) be downward-looking, i.e., starting from the
phenomenon and searching for what elicits it, or upward-looking, i.e., studying the contri-
bution of a component to a phenomenon or a system’s overall behavior. Without going
into the philosophical details here, let us add that classifications with respect to (i)–(iii) are
independent of one another. It is worth pointing out, though, that exploratory research
and experiments utilizing mere-interactions tend to be more common at the beginning
of a research process whereas intervention-based hypothesis-testing research tends to be
more common when a research tradition has matured, and results are being published [37].
Against this background, it is little surprising that the dominant view of biochemistry is
not only that it focuses on downward-looking research but also that it utilizes interventions
and hypothesis testing. Indeed, most research is being conducted and published once a
research tradition has matured.
Again, what do we learn from this about MT research? First, we already noted
that MT research is mostly an upward-looking search for the function of a biochemical
component. And though this may not be the way biochemists typically identify what
molecules serve which biological function, this can actually be a successful research strategy,
as we shall discuss in Section 4. Second, we can now recognize that Vallee’s research was
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exploratory in nature—he did not have any pre-established theories and he was not trying
to test hypotheses—and that his methodology was based on mere interactions, such as
spectroscopy. While these features may also seem intriguing if compared to the large body
of published research in biochemistry, it is little surprising to find exploratory and mere
interaction-based research where and when a molecule is discovered first. For this simply
marks the beginning of a research tradition, in our case the hunt for the elusive function of
MTs [16]. The fact that Valle later actually did inject CdCl2 into animals to study its effects
does not undermine this point; his initial research on MTs was clearly exploratory in nature
and based on mere interactions. As we shall discuss in the next Section, MT research has
developed into a more hypothesis-testing and intervention-based research tradition since
the 1960s. Nonetheless, it remained very much focused on upward-looking research.
3. The Enigmatic Role of Vertebrate MTs
Although MTs have been identified in many organisms—many prokaryotes and
almost every eukaryote carry genetic information encoding MTs—mammalian MTs are
the ones studied most. This is likely because MTs have been identified first in mammalian
tissue. Since the initial discovery of MTs, biochemistry has made significant progress with
respect to characterizing and classifying vertebrate MTs. By now, we accept that MTs are
metalloproteins which have an exceptionally high sulfur content concentrated in 20 cysteine
residues and therefore can bind up to seven Zn2+ or Cd2+ ions or 12 Cu+ ions. The high
negative charge of the unique metal-sulfur clusters, such as the Zn4Cys11-α-clusters and
Zn3Cys9-β-clusters in MT-1 and MT-2, is balanced by seven lysine residues, resulting in
the equally unique dumbbell shape of the MT proteins which sets them apart from many
other biomolecules found in nature [38,39]. Other primary structures of MTs comprising
diverse Cys content and coordination, hence varying in metal load and affinities, have been
documented [40–42].
In human cells, three different subfamilies have been identified, i.e., MT1/2 expressed
and induced in almost every cell, MT3 in the nervous system and MT4 in the squamous
epithelia [43,44]. Phylogenic analyses further categorize these subfamilies into subgroups,
i.e., m1P1 and m2P2 as subgroups of MT1 and MT2, respectively, in humans. From these
subgroups several human isoforms are specified e.g., MT1A and MT1B. Genetically, human
MT1 and MT2 are much less discrete than MT3 and MT4. In fact, MT2 is a member of the
MT1 branch, as shown in Figure 2 [13,45]. Though we shall not go into the specifics here,
note that similar details have been established already about the biochemical properties
of and phylogenetic relations between MTs in other organisms (e.g., [42]). Despite such
detailed information, however, the phylogenetic tree of the MT family is still unrooted and
researchers’ insights into the function of MTs remain very limited to date [15,44,46].
Still, the widespread prevalence of MTs across organisms and their unique biochemical
properties suggest that MTs serve, or at least have served, as we shall elaborate below, some
important biological role(s). Recent studies have reported a divergence in the function(s)
of MTs based on the type of cysteine motifs in invertebrates and vertebrates [40,47]. The
new γ domain identified in Patellogastropoda, for instance, favors cadmium over zinc
and is more resilient against demetallation [40]. Thus, the γ domain may be alluding to
a specialized metal detoxification function in this natural group. It should also be noted
that a role for the noncoordinating amino acids is also being recognized, such as in the
case of Nerita peloronta MT1 and MT2 (NpeMT1 and NpeMT2) [40,48]. Yet, while the
evolutionary forces and developments may be understood better in evolutionarily older
and less complex organisms, even here the jury is still out with respect to both the precise
function(s) of MTs and their evolutionary history (e.g., [41,49]). We shall return to this in
Section 5. For now, we shall focus our attention on thefunction of MT in mammals as this
has been the main focus of MT research since their discovery in 1957.
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In the late 20th, research has focused on the reactivity and sensitivity of the cysteine lig-
ands towards metalation, oxidation and reduction and the related physiological pathology
in mammals [50–55]. Three main functions have been proposed over the past 60 years for
vertebrate MTs: (i) metal detoxification or toxic metal metabolism, (ii) metal homeostasis or
essential metal metabolism, and (iii) protection from oxidative stress (OS). In what follows
we shall briefly review these hypotheses and the main research associated to them.
3.1. Metal Detoxification or Toxic Metal Metabolism
As the first MTs were isolated from Cd2+-poisoned horses, the notion of MTs as detoxi-
fying proteins for heavy metals has been postulated. MT knock out mice are reported to be
more sensitive to tissue damage in response to the administration of cadmium, in addition
to other in vivo studies reporting an upregulation of MTs after such administration [56–58].
A free Cd2+ ion inside the cell displaces zinc from MTs leading to an increase in the intra-
cellular concentration of free Zn2+. The displaced Zn2+ ion is picked up by a zinc sensitive
pr tein, i.e., metal response transcription Factor 1 (MTF-1) which is then translocated to
the nucleus of the cell. The inducti n of thionein, the unm talated apo form of MT, is the
initiated by a tra scription promoter called metal response element (MRE). The affi ity of
MTs o metal ions follows the binding constant of thiolates (Hg2+ > Cu+ > Cd2+ > Zn2+).
In our example, the excess zinc liberated fro MT is th n sequestered by this additional
thionein. Inside the cell, however, MTs are mostly coordinated to either zinc or copper, two
essential and beneficial etals, thus MTs linked to cadmium and other heavy m tals are
assumed to result from exposure to environmental factors [59].
3.2. Metal Homeostasis or Essential Metal Metabolism
Native MTs isolated from mammalian cells are generally bound to zinc and copper
ions Bo h metals are metabolically important and their intracellular free ion concentrations
reside in the picomolar range, despite their micromolar total intracellular content. Zinc
has catalytic, structural, and regulative roles in the biology and is a cofactor in about
3000 human proteins [60,61]. As opposed to a previous conception of the metalation
mechanism of MTs which was suggested to be of a cooperative nature, i.e., the binding
of one zinc ion, for instance, would facilitate the binding of the next zinc ion and so on
and there would be a notable absence or instability of partially metalated MTs within the
cell, mounting evidence demonstrates that MTs bind metal ions uncooperatively [62]. Such
findings have important implications on our understanding on how MTs are involved in
the metabolism of essential trace metals. MTs are no longer regarded as zinc storages or
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thermodynamic sinks, rather as an active component in both the regulative and cellular
signaling pathway of zinc, therefore tightly controlling its transient concentration as a
protein buffer.
3.3. Protection from OS or Antioxidant Scavengers
The antioxidant function of MTs has been proposed due to the exceptionally rich
cysteine content (30%) and the fact that OS also leads to upregulation of these proteins [63].
In vitro and in vivo studies, for instance, have demonstrated that ZnMTs scavenge free
radicals when treated with hydrogen peroxide (H2O2) and release Zn2+ which in turn leads
to the induction of the highly reactive thioneins and MTs through MTF-1 and MRE. Reactive
oxygen species (ROS) easily oxidize MTs resulting in their cellular upregulation mediated
by an antioxidant response element (ARE) activated by an ARE-binding transcription
factor [64]. Increased expression of these proteins mitigates reperfusion injury in the
muscle tissues of the heart [65]. It has also been reported that MTs inhibit the copper
induced hydroxyl radical HO•.
3.4. Quo Vadis?
What do we learn from this? Put briefly: despite thousands of studies describing the
structure, biochemical characteristics, and tissue distributions of MTs, and even specific
suggestions for what role(s) MTs might play in vertebrate organisms, the actual function of
the MT family still remains enigmatic [15,16].
We might wonder why that is and whether, maybe, there is some sort of systematic
problem with MT research. Indeed, some authors have highlighted that MT research faces
several non-trivial experimental difficulties [7,62]. For instance, applying X-ray diffraction
has provided substantial insights into the dumbbell shaped crystalline structure of MTs.
Yet such experiments are reported to face significant difficulties and hence, most of the
structural characteristics are obtained through NMR analyses which illuminate the coordi-
nation of metal-thiolate ligands in the two functional domains but not how they connect
and interact [66–68]. Another difficulty stems from the fact that d10 metals are chromophor-
ically silent in spectroscopic essays. Hence, when studying metal ion transfer scientists
substitute zinc with cobalt as a spectroscopic probe [69]. Moreover, the in vitro studies of
MTs do not account for the in vivo heterogeneity of these proteins, notably their varying
amount and content of metal ions, and the structural models are derived from just one
isoform, i.e., Zn4Cys11-α-clusters and Zn3Cys9-β-clusters [7,15]. Due to such unavoidable
experimental limitations, one might argue, it is difficult to make general claims about the
function of MTs. But is this really a systematic weak point of MT research? Limited, indirect
or suboptimal experimental methodologies and tools are common across the empirical
sciences. In addition, and quite generally speaking, this does not prohibit progress in
principle. Neuroscientists, for instance, study the brain with all kinds of epistemically
limited tools. Still, we have a good idea about what certain structures and molecules in the
brain do. To be fair, methodological limitations surely are not making it easier to identify
MTs’ function(s). Yet that is hardly the sole reason for us not being able to establish what
the function(s) of MTs are.
If limited experimental methods are not the issue, one might suspect that identifying
MT functions does not currently get off the ground due to the kinds of experiments
employed. Based on our exposition in Section 2, however, we can conclude that a focus on
exploratory research and mere interactions is neither special nor problematic for an episode
of scientific inquiry which lays the foundations of and for a new research tradition. And
indeed, recent MT research—as we have just outlined—has moved well beyond this. Over
time, there have been theories developed, hypotheses proposed and tested, interventions
carried out, etc. So what is left then is the upward-looking character of the overall MT
research tradition: if the prototypical approach in biochemistry is to start with a function
and search for the molecule(s) relevant for that function, having a molecule and searching
for its function might seem a bit like putting the cart before the horse. The attentive reader
Int. J. Mol. Sci. 2021, 22, 5984 9 of 16
may suspect this is whence a potential systematic problem might originate. Though, as we
shall show in the next section, it is not actually as simple as that either.
4. The Case of Ceruloplasmin
To grasp why upward-looking research is not in principle unable to pinpoint a
molecule’s function, consider hemoglobin. Hemoglobin is an iron metalloprotein present
in the blood cells of almost each of the vertebrates and some invertebrates. It was discov-
ered first in samples of earthworm blood by Friedrich Ludwig Huenefeld (1799–1882) in
1840 [70,71]. While its function was initially unknown, 30 years later French physiologist
Claude Bernard (1813–1878) [72] recognized the oxygen carrying property of hemoglobin.
For a more recent example, consider the case of ceruloplasmin. In 1944, Carl G.
Holmberg (1906–1991) reported the observation of a unique blue coloration in his insoluble
serum fractionation sample, PI-fraction [73]. The blue color reminded him of the inactive
copper protein isolated by Mann and Keilin in 1938 from the red blood cells of equine
serum, named hemocuprein, an enzyme soon referred to as superoxide dismutase (SOD).
This inspired Holmberg to identify the copper content of the PI-fraction [73]. He quickly
realized that this small fraction of the serum contained “ . . . proportionally about five times
as much copper as the serum protein as a whole,” ([73] p. 228). Holmberg also noted that
the blue color could be oxidized and reduced reversibly, hinting at an enzymatic activity.
Today, ceruloplasmin is accepted to play an important role in iron metabolism and as be the
main storage for copper in the human body, accounting for 95% of the total body content
of this trace metal [74,75].
Both these cases clearly illustrate that searching for a molecule’s functions is, at least
sometimes, a successful research strategy in biochemistry. Put slightly differently, that is to
say upward-looking research programs are not in principle impossible or systematically
flawed. They are viable and can indeed be successful. Thus, the fact that the function of
MTs has not yet been identified cannot be blamed on the fact that the search started from
the molecule. If this is correct, the reader may wonder, what is left? How come we still
cannot say what the function of MTs is? In the next section, we shall offer a few other
considerations which might be helpful to advance our understanding of the enigmatic MTs.
5. Beyond One-to-One Mappings
From a philosophy of science point of view, searching for “the” one function of a
biochemical molecule seems highly idealized. And even if upward-looking research has
been successful to associate other molecules with a specific function, that is no guarantee
that this strategy will work for the MT family. No doubt, each of the functions suggested
for MTs has seemed worthy to pursue at some time (cf. Section 3). Yet, given that there
is not much progress being made based on the assumption that MTs serve some sort of
unitary evolved biological function, we might have to change track. In what follows,
we propose two ways of thinking which might facilitate new research agendas. Note
that while our suggestions here originate mainly from considerations of research on a
phylogenetically relatively young branch of the MT family, namely vertebrate MTs, recent
studies on invertebrate MTs appear to actually support our suggestions [40,44,49].
5.1. Multiple Realization, Robustness, and Moonlighting
The first set of considerations we would like to offer revolves around the notion that
one-to-one mappings between biochemical components and biological functions might
not be realistic. For instance, MTs might serve an important biological function, yet that
function might not actually be unique to MTs. What MTs do in biological organisms
might also be achieved by other biochemical molecules. For an example of multiple
realization, consider the case of hemophilia. Hemophilia is a devastating medical condition
characterized by a malfunctioning clotting mechanism, resulting in a potentially life-
threatening extended bleeding time. At least three types of hemophilia have been identified,
Hemophilia A, B and C, each corresponding to deficiencies in a different clotting factor
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either genetically or due to pregnancy, autoimmune diseases, or cancer. For a long time,
the distinction between the three types went unnoticed [76]. In 1952, Christmas disease,
which is now known as Hemophilia B, was suggested [77]. The researchers started from
the observations that adding small amounts of normal blood to blood samples from
hemophilic patients reduces the clotting time and that in some cases a similar time reduction
is observed when mixing two hemophilic samples from different patients. When the
isolated antihemophilic globulin, now called as Factor VIII, was added to some of the
hemophilic samples no reduction in clotting time was observed. This indicated a variation
in the underlying clotting factor responsible for the prolonged clotting period. Further
fractionation and precipitation of the blood samples from the Christmas disease patients
demonstrated an absence of a specific protein, when compared to normal blood and
hemophilic samples lacking Factor VIII which is characteristic of Hemophilia A. This active
protein was called thereafter, Christmas Factor or Factor IX.
What is noteworthy about hemophilia is that there is not just one biochemical factor
eliciting it, but three different ones. Thus, we see a mapping from one phenomenon (a
biological function) to many molecules exhibiting that function (we might consider this
a case of multiple realization). Now if we assume that this is the case for MTs, too, we
would basically have to expect that MTs serve as one of multiple realizers for one or many
functions. If so, this might explain why upward-looking research is actually at its limit to
uncover the role MTs play in biological organisms; for identifying different biochemical
components relevant to a single phenomenon requires knowing what the phenomenon in
question is and carrying out downward-looking research. To this end, most of, if not all,
the upward-looking MT research done to date will provide useful clues, but it simply will
not be conclusive.
Another, though related, reason why it might be so difficult to pin down the biological
function(s) of MTs could be that their function(s) might be compensated for easily by other
biochemical components or mechanisms if MTs are missing. Or, conversely, MTs might
themselves serve a compensatory function in case other important structures or mecha-
nisms fail to operate. The existence of such compensatory mechanisms is at least quite
plausible. Ultimately, we know that redundancy and plasticity are important principles
contributing to the robustness of phenotypic traits rendering organisms fit for survival [78].
For instance, consider connexins (Cx), the transmembrane proteins which allow the ex-
change of small molecules between neighboring cells [79]. Cx36 compensates for the
function of Cx45 in the retina and Cx32 has been reported to compensate for Cx43 [80,81].
Still, if this way of thinking is correct, the question remains how MT researchers might
work their way through the thickets of metabolism in various species to understand the
precise role of the MT family.
A third, and the perhaps the most likely option is that although MTs form a seem-
ingly united family of proteins they actually serve a host of different functions in various
biological organisms. That is to say, we have a single biochemical molecule that does
multiple things in a biological organism. For illustration, consider the case of Glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH). In glycolysis, GAPDH serves an enzymatic
function catalyzing the sixth step of the reaction, i.e., the conversion of glyceraldehyde
3-phosphate to D-glycerate 1,3-bisphosphate. GAPDH has been functionally linked to
several non-metabolic functions such as initiation of cell death, transcription of DNA,
participation in the antioxidant defense mechanism and metal chaperoning [82–85].
If something like this is also the case for MTs, one might wonder where the multifunc-
tionality of MTs might come from. Recent discussions about protein moonlighting [86,87]
suggest an answer: biochemical molecules can actually acquire new and diverse functions
through evolution. Proteins can have moonlighting functions based on their localization
intracellularly or extracellularly, the types of cells expressing them, the type of substrate
available, their quaternary structure (monomers or multimers), or their interaction with
other proteins to form more complex structures and multiplicity of binding sites [88].
Within this context, some sort of accidental or systematic biochemical resemblance despite
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diverse functionality seems at least plausible—and perhaps more feasible than to expect
a one-to-one mapping between biological functions and biochemical molecules. If this is
correct, searching for “the function” of MTs might not be a productive research strategy.
We might be better off asking where the MT family comes from and how it has developed.
5.2. Evolutionary Effects: Vestiges, Exaptation, and Convergent Evolution
The second set of considerations we would like to offer originates from the following
question: What if the answer to the question of why MTs are so widespread cannot be
found in their current but rather in their past biological function? In other words, we
would like to point to some evolutionary considerations.
First, we might wonder whether MTs could be vestiges of some sort. That is to say,
could they be residues from our evolutionary ancestry which no longer have a biological
function? Given how widespread MTs are throughout the animal and plant kingdom,
however, MTs would have to go back very far and, there would have to be a common
root in the phylogenetic tree of MTs which so far seems to be missing (cf. Section 3). As
an example of a vestigial molecular structure in humans consider the cyritestin genes
CYRN1 and CYRN2. In other mammals, such as mice, CYRN1 and CYRN2 play an
essential role in fertility although they seem to be non-functional in humans [89–91]. Other,
more conspicuous, vestigial structures in humans are the appendix and the coccyx, i.e.
the tailbone.
In light of this, we might consider another option. Namely that the MT family might
actually be a result of convergent evolution. That is to say, the same kind of biochemi-
cal molecule evolved in different species to perform different, though possibly related,
functions. Maybe these functions are somehow linked to metabolizing metals and that
is what makes the sulfur-rich metalloproteins such a good candidate molecule for the
jobs in question. Contemporary research on invertebrate MTs actually lends support to
these evolutionary considerations [40,42,49]. Genetic and biochemical data from mollusks
suggests that MTs might have played crucial roles in metal detoxification throughout early
evolution. More recently, MTs may have become relevant for homeostasis as living beings
adapted to increasingly variable environments [40,92–95]. Since MTs are somewhat flexible
and can change in response to environmental factors, their various forms might have been
crucial for organisms to adapt to variable situations of metal bioavailability. Nonetheless,
these findings are not yet sufficient to understand the evolution of MTs. Neither is it
clear whether and to which extent findings about invertebrate MTs will inform vertebrate
MT research. In fact, the evidence reported thus far does not disambiguate between the
hypotheses of vertebrate MTs being vestiges of an invertebrate evolutionary history or the
result of convergent evolution in response to certain needs for adaptation. A complete phy-
logenetic tree of the MT family might help to disentangle these scenarios—unfortunately,
though, that is not currently available [15,47,96].
Relatedly, MTs might have had some crucial shared biological function which has
shifted throughout evolution, i.e., they might be a result of exaptation. If so, we nonetheless
may find a family of MTs united by a shared biochemistry which now serves different
functions in different species or organisms. Calatayud et al.’s suggestion of mollusk MTs
having been used for detoxification before they have become important for homeostasis
hints in this direction [40]. Indeed, this is perhaps the most promising among our evolu-
tionary considerations: it is effectively a version of the many-functions hypothesis outlined
above. Since it is compatible with moonlighting, it comes with a candidate mechanism
for how multiple functions have been acquired by the MT family. Further, and as such, it
also comes with an evolutionary explanation for the shared biochemistry despite varied
functionality within the MT family. Besides, this scenario does not require a common root
in the phylogenetic tree because it does not require all MTs to have some sort of common
ancestor. At the same time, this scenario is compatible with the idea that most MTs did
serve some sort of unitary function at some point in evolutionary history.
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Note that the scenarios just described might not be mutually exclusive. In fact, it
is possible that MTs first entered the scene independently, then convergently evolved
to serve some common or shared function, and then—different organisms faced varied
evolutionary pressures as they adapted to different environments—exapted to serve different
functions across species or organisms. Obviously, this is merely a theoretical scenario for
now. Nevertheless, the most recent data on mollusk MTs lends support to the notion that
research into the linage-specific and evolutionary old functions of MTs might help us not
only to uncover the ancient functions of MTs but also their prevalence and function across
animal phyla today, including evolutionarily younger and more complex organisms such
as vertebrates. Thus, modifying the research strategy for investigating the function(s) of
MTs by focusing on their evolutionary history provides a very promising outlook.
6. Conclusions
Research on MTs has started initially from the recognition that these proteins are
extremely prevalent across the animal and plant kingdoms. “Why do so many species have
MTs?” was thus interpreted as a question about MTs’ function, demanding researchers to
find out what MTs are good for. Nonetheless, having an important biological function today
is not the only possible reason for why some biochemical molecule may be abundant across
most of the taxonomic kingdoms. The hypotheses we outlined in Section 5 acknowledge
that and we suggest that—rather than searching for the function of MTs—we should ponder
about possible origins of MTs to explain their prevalence. Focusing on the evolutionary
history of MTs rather than their contemporary function has the potential to resolve the
question of why MTs are so prevalent across species. As such, it has a high problem-solving
capacity or programmatic character [97] and thus presents a pursuit-worthy research
strategy likely to elicit scientific progress (e.g., [98,99]).
Of course, none of the suggestions we put forward in the previous section are full-
fledged theories of vertebrate MT function. Yet, they might offer useful hypotheses for
experts in the field to pursue—especially given that similar considerations have already
been offered in the context of evolutionary studies of invertebrate MTs. What we can
conclude at this point is the following: Despite the special circumstances of the discovery of
MTs, there is probably nothing systematically amiss in the research tradition. What appears
so intriguing about Vallee’s early work is actually characteristic of discovery episodes
leading towards the foundation of a research tradition: upward-looking and exploratory
research involving mere interactions. Besides, the upward-looking search for functions
is—at least in principle—a viable strategy which has been successful in some cases, as
discussed in see Section 4. It is neither in principle fruitless nor systematically flawed.
Nonetheless, it looks as if MT research has not been going forward as much as bio-
chemists would have liked it to and the biological role(s) of MTs still remain enigmatic,
especially for vertebrates. This should motivate us to seek a different direction for con-
temporary MT research. The suggestions we presented in Section 5 provide some options.
That they converge with recent empirical work on the evolution of mollusk MTs highlights
two things: first, it shows that a systematic philosophical analysis of empirical research
may offer support for empirical research decisions. Second, it emphasizes the pursuit-
worthiness of evolutionary MT research. That is to say, it renders evolutionary approaches
even more likely to solve the research problem at hand and to elucidate why MTs are so
prevalent, what precisely they do, and where they come from—in ancient and also in recent
animal phyla.
Author Contributions: Conceptualization, A.Y.A., C.J. and L.K.; investigation, A.Y.A.; supervision,
C.J. and L.K.; validation, C.J. and L.K.; visualization, A.Y.A.; writing—original draft, A.Y.A., C.J. and
L.K.; writing—review and editing, A.Y.A., C.J. and L.K. All authors have read and agreed to the
published version of the manuscript.
Funding: This article is based upon work from Saarland University, Saarbruecken, Germany, the
COST Action NutRedOx-CA16112 supported by COST (European Cooperation in Science and
Int. J. Mol. Sci. 2021, 22, 5984 13 of 16
Technology), the “Landesforschungsfoerderungsprogramm” of the State of Saarland (Grant No.
WT/2—LFFP16/01) and with the support of the Erasmus + program of the European Union, Saarland
University (SAARBRU01). We acknowledge support by the Deutsche Forschungsgemeinschaft
(DFG, German Research Foundation) and Saarland University within the funding programme Open
Access Publishing.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: No new data were created or analyzed in this study. Data sharing is
not applicable to this article.
Acknowledgments: We would like to thank Michèle Friend and Sébastien Paul from UCCS, Centrale
Lille, and Jawad Nasim along the many other colleagues from the Pharmasophy and Academiacs
International networks (www.academiacs.eu accessed on 31 May 2021) as well as from the EIS
(Explainable Intelligent Systems) project team for their helpful discussions and advice. We extend
our deep gratitude to Wolfgang Maret and Philip Haueis for their advice and orientation. Finally, we
would like to thank the anonymous reviewers who indeed helped us improve the overall quality of
the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Vallee, B.L.; Hoch, F.L. Zinc, a component of yeast alcohol dehydrogenase. Proc. Natl. Acad. Sci. USA 1955, 41, 327–338. [CrossRef]
2. Vallee, B.L. Metallothionein: Historical Review and Perspectives. Exp. Supply 1979, 34, 19–40. [CrossRef]
3. Margoshes, M.; Vallee, B.L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 1957, 79, 4813–4814. [CrossRef]
4. Kägi, J. Piscator. In Metallothionein, Proceedings of the First International Meeting on Metallothionein and Other Low Molecular Weight
Metal-Binding Proteins, Zürich, Switzerland, 17–22 July 1978; Springer: Basel, Switzerland, 2013; ISBN 978-3-0348-6493-0.
5. Kagi, J.H.; Valee, B.L. Metallothionein: A Cadmium- and Zinc-Containing Protein from Equine Renal Cortex. J. Biol. Chem. 1960,
235, 3460–3465. [CrossRef]
6. Vallee, B.L. Implications and Inferences of Metallothionein Structure. In Metallothionein II, Proceedings of the Second International
Meeting on Metallothionein and Other Low Molecular Weight Metalbinding Proteins, Zürich, Switzerland, 21–24 August 1985; Kägi,
J.H.R., Kojima, Y., Eds.; Experientia Supplementum; Birkhäuser: Basel, Switzerland, 1987; pp. 5–16. ISBN 978-3-0348-6784-9.
7. Palacios, O.; Atrian, S.; Capdevila, M. Zn- and Cu-Thioneins: A Functional Classification for Metallothioneins? J. Biol. Inorg.
Chem. 2011, 16, 991–1009. [CrossRef] [PubMed]
8. Dunn, M.A.; Blalock, T.L.; Cousins, R.J. Metallothionein. Proc. Soc. Exp. Biol. Med. 1987, 185, 107–119. [CrossRef]
9. Davis, S.R.; Cousins, R.J. Metallothionein Expression in Animals: A Physiological Perspective on Function. J. Nutr. 2000, 130,
1085–1088. [CrossRef] [PubMed]
10. Koh, J.-Y.; Lee, S.-J. Metallothionein-3 as a Multifunctional Player in the Control of Cellular Processes and Diseases. Mol. Brain
2020, 13, 116. [CrossRef]
11. Rono, J.K.; Le Wang, L.; Wu, X.C.; Cao, H.W.; Zhao, Y.N.; Khan, I.U.; Yang, Z.M. Identification of a New Function of
Metallothionein-like Gene OsMT1e for Cadmium Detoxification and Potential Phytoremediation. Chemosphere 2021, 265, 129136.
[CrossRef]
12. Jacob, C.; Maret, W.; Vallee, B.L. Control of Zinc Transfer between Thionein, Metallothionein, and Zinc Proteins. Proc. Natl. Acad.
Sci. USA 1998, 95, 3489–3494. [CrossRef]
13. Binz, P.-A.; Kägi, J.H.R. Metallothionein: Molecular evolution and classification. In Metallothionein I; Klaassen, C.D., Ed.; Advances
in Life Sciences; Birkhäuser: Basel, Switzerland, 1999; pp. 7–13. ISBN 978-3-0348-8847-9.
14. Freisinger, E. Structural Features Specific to Plant Metallothioneins. J. Biol. Inorg. Chem. 2011, 16, 1035–1045. [CrossRef] [PubMed]
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